In turn, the mTOR pathway has been shown to be one of the most important pathways involved in the development and progression of cancer and in the maintenance and hallmarks of CSCs 50, implying that inhibition of the mTOR pathway could be a good therapeutic strategy to eradicate CSCs. The gene discussed is MTOR; the disease is cancer.